［1］ CALLIER V.Core concept:Solving peto's paradox to better understand cancer［J］.Proc Natl Acad Sci USA,2019,116(6):1825-1828.
［2］ GOTWALS P,CAMERON S,CIPOLLETTA D,et al.Prospects for combining targeted and conventional cancer therapy with immunotherapy［J］.Nat Rev Cancer,2017,17(5):286-301.
［3］ CUI R,MODEIROS T,WILLEMSEN D,et al.Relaxed selection limits lifespan by increasing mutation load ［J］.Cell,2019,178(2):385-399.
［4］ ROZHOK AI,DEGREGORI J.Toward an evolutionary model of cancer:Considering the mechanisms that govern the fate of somatic mutations［J］.Proc Natl Acad Sci USA,2015,112(29):8914-8921.
［5］ MADAN E,PELHAM CJ,NAGANE M,et al.Flower isoforms promote competitive growth in cancer［J］.Nature,2019,572(7768):260-264.
［6］ MADHUSOODANAN J.News feature:Do hosts and their microbes evolve as a unit ［J］.PNAS,2019,116(29):14391-14394.
［7］ PICH O,MUINOS F,SABARINATHAN R,REYES-SALAZAR I,et al.Somatic and germline mutation periodicity follow the orientation of the DNA minor groove around nucleosomes［J］.Cell,2018,175(4):1074-1087.e18.
［8］ KAZAZIAN HH JR,MORAN JV.Mobile DNA in health and disease［J］.N Engl J Med,2017,377(4):361-370.
［9］ KAUFMAN CK,MOSIMANN C,FAN ZP,et al.A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation ［J］.Science,2016,351(6272):aad2197.
［10］ GREAVES M.When one mutation is all it takes［J］.Cancer Cell,2015,27(4):433-434.
［11］ SOTTORIVA A,KANG H,MA Z,et al.A Big Bang model of human colorectal tumor growth ［J］.Nat Genet,2015,47(3):209-216.
［12］ ROZHOK AI,DEGREGORI J.The evolution of lifespan and age-dependent cancer risk［J］.Trends Cancer,2016,2(10):552-560.
［13］ 张百红，岳红云.肿瘤状态的改变［J］.西北国防医学杂志,2016,37(4):261-264.
ZHANG BH,YUE HY.Changes of cancer status before and after therapy［J］.Med J NDFNC,2016,37(4):261-264.
［14］ FILLON M.Low-cost online cascade test may persuade relatives to investigate their own cancer risk［J］.CA Cancer J Clin,2019,69(2):86-87.
［15］ LANDHUIS E.Science and culture:Cancer researcher looks to artists for inspiration［J］.Proc Natl Acad Sci USA,2018,115(5):826-827.
［16］ LAZARIS C,AIFANTIS I,TSIRIGOS A.On epigenetic plasticity and genome topology［J］.Trends Cancer,2020,6(3):177-180.
［17］ FAIS S,OVERHOLTZER M.Cell-in-cell phenomena in cancer［J］.Nat Rev Cancer,2018,18(12):758-766.
［18］ ONDECK MG,KUMAR A,PLACONE JK,et al.Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling［J］.Proc Natl Acad Sci USA,2019,116(9):3502-3507.
［19］ SHURER CR,KUO JC,ROBERTS LM,et al.Physical principles of membrane shape regulation by the glycocalyx［J］.Cell,2019,177(7):1757-1770.
［20］ MOHAMMADI H,SAHAI E.Mechanisms and impact of altered tumour mechanics［J］.Nat Cell Biol,2018,20(7):766-774.
［21］ BALANI S,NGUYEN LV,EAVES CJ.Modeling the process of human tumorigenesis［J］.Nat Commun,2017,8:15422.
［22］ FINN EH,PEGORARO G,BRANDAO HB.Extensive heterogeneity and intrinsic variation in spatial genome organization［J］.Cell,2019,176(6):1502-1515.
［23］ MATTEO LIGORIO,SRINJOY SIL,JOSE MALAGON-LOPEZ.Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer［J］.Cell,2019,178(1):160-175.
［24］ BHATT AP,REDINBO MR,BULTMAN SJ.The role of the microbiome in cancer development and therapy［J］.CA Cancer J Clin,2017,67(4):326-344.
［25］ MALLET DE LIMA CD,GONAOR A.Circadian organization of the genome［J］.Science,2018,359(6381):1212-1213.
［26］ PANDA S.Circadian physiology of metabolism［J］.Science,2016,354(6315):1008-1015.
［27］ MAN K,LOUDON A,CHAWLA A.Immunity around the clock［J］.Science,2016,354(6315):999-1003.
［28］ HORVATH S,RAJ K.DNA methylation-based biomarkers and the epigenetic clock theory of ageing［J］.Nat Rev Genet,2018,19(6):371-384.
［29］ OLSHANSKY SJ.Ageing:Measuring our narrow strip of life［J］.Nature,2016,538(7624):175-176.
［30］ GARON EB,HELLMANN MD,RIZVI NA,et al.Five-year overall survival for patients with advanced non-small-cell lung cancer treated with pembrolizumab:Results from the phase I KEYNOTE-001 study［J］.J Clin Oncol,2019,37(28):2518-2527.
［31］ IM SA,LU YS,BARDIA A,et al.Overall survival with ribociclib plus endocrine therapy in breast cancer［J］.N Engl J Med,2019,381(4):307-316.
［32］ MCGRANAHAN N,SWANTON C.Clonal heterogeneity and tumor evolution:Past,present,and the future［J］.Cell,2017,168(4):613-628.
［33］ FEINBERG AP.The Key role of epigenetics in human disease prevention and mitigation［J］.N Engl J Med,2018,378(14):1323-1334.
［34］ SAOTOME K,MURTHY SE,KEFAUVER JM,et al.Structure of the mechanically activated ion channel Piezo1［J］.Nature,2018,554(7693):481-486.
［35］ PAN Y,YOON S,SUN J,et al.Mechanogenetics for the remote and noninvasive control of cancer immunotherapy［J］.Proc Natl Acad Sci USA,2018,115(5):992-997.
［36］ GOMEZ JL,BONAVENTURA J,LESNIAK W,et al.Chemogenetics revealed:DREADD occupancy and activation via converted clozapine［J］.Science,2017,357(6350):503-507.
［37］ MENARD C,RUSSO SJ.Non-invasive chemogenetics［J］.Nature Biomedical Engineering,2019,2:467-468.
［38］ 张百红，岳红云.肿瘤的光遗传学治疗［J］.肿瘤防治研究,2018，45（12）：1023-1026.
ZHANG BH,YUE HY.Optogenetics therapy of human cancers［J］.Cancer Res Prev Treat,2018，45（12）：1023-1026.
［39］ BAILEY SR,MAUS MV.Gene editing for immune cell therapies［J］.Nat Biotechnol,2019,37(12):1425-1434.
［40］ PANDA S.The arrival of circadian medicine［J］.Nat Rev Endocrinol,2019,15(2):67-69.
［41］ EL-DEIRY WS,GOLDBERG RM,LENZ HJ,et al.The current state of molecular testing in the treatment of patients with solid tumors,2019［J］.CA Cancer J Clin,2019,69(4):305-343.
［42］ ADAM D.How a data detective exposed suspicious medical trials［J］.Nature,2019,571(7766):462-464.
［43］ MOK TS,CHENG Y,ZHOU X,et al.Improvement in overall survival in a randomized study that compared dacomitinib with gefitinib in patients with advanced non-small-cell lung cancer and EGFR-activating mutations［J］.J Clin Oncol,2018,36(22):2244-2250.
［44］ SANMAMED MF,CHEN L.A Paradigm shift in cancer immunotherapy:from enhancement to normalization ［J］.Cell,2018,175(2):313-326.
［45］ ZHANG S,SCOTT EY,SINGH J,et al.The optoelectronic microrobot:A versatile toolbox for micromanipulation［J］.Proc Natl Acad Sci USA,2019,116(30):14823-14828.